As a leading supplier in the Chinese biotech sector, we specialize in the stabilization of Lactobacillus Acidophilus. Leveraging advanced lyophilization (freeze-drying) technology, our strains maintain superior viability (CFU/g) and gastrointestinal tract (GIT) transit resistance. Our expertise ensures that every batch meets the most stringent international pharmacopoeia standards.
We are integrating multi-layer encapsulation technologies to protect probiotics from gastric acidity, ensuring maximum efficacy in human clinical applications.
Expanding our R&D into personalized probiotic formulations and synbiotic combinations to address specific metabolic health requirements.
Proactive adoption of predictive analytics to align production capacity with the surging global demand for immune-supporting functional ingredients.
Our production facilities represent the pinnacle of "China Factory 4.0". By implementing automated clean-room monitoring, real-time batch traceability, and redundant cold-chain logistics, we minimize the variance typical of traditional manufacturing. This resilience guarantees that our Lactobacillus Acidophilus arrives at your facility with the exact potency specified in our COA.
We understand the complexities of global procurement—from REACH compliance in the EU to FDA facility registration in the US. Our dedicated regulatory affairs team provides comprehensive documentation (DMF, MSDS, Stability Reports) to facilitate smooth customs clearance and local certification processes.
Our freeze-drying process ensures >90% stability at 24 months when stored under recommended temperatures (2-8°C).
Yes, we offer both bulk powder and finished dosage form (sachets/capsules) packaging solutions tailored to your brand.
All our Lactobacillus strains are strictly non-GMO and cultivated in food-grade, allergen-controlled environments.